DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sharda Cropchem Limited — Outcome of Board Meeting

NSE 56 min ago·30 Oct 2026, 8:00 am

Sharda Cropchem

Sharda Cropchem Limited has informed the stock exchanges regarding its financial results for the period ending September 30, 2026. The company has submitted these updates to the exchange, which means the detailed financial statements are now available for public review.

For investors, this disclosure is a routine but important update. It allows shareholders to assess the company's current financial health and operational performance. Market participants will likely analyze the figures to gauge the company's trajectory and make informed investment decisions.

Investors should look for key metrics such as revenue growth, profit margins, and any commentary from the management regarding future outlook. Keeping an eye on the detailed financial report will help in understanding the company's standing in the market.